Position in GSK
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,227,011
-$152,174 QoQ
Shares Held
42,484
-1.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#240
of 1,032 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FOSTER & MOTLEY INC holds $58,493,564 across 11 Drug Manufacturers - General names. GSK ranks #8 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
57,981 | $14,590,338 | |
| 2 | AMGN |
Amgen Inc
|
32,896 | $11,912,299 | |
| 3 | JNJ |
Johnson & Johnson
|
45,340 | $11,514,999 | |
| 4 | MRK |
Merck & Co., Inc.
|
38,282 | $4,919,237 | |
| 5 | PFE |
Pfizer Inc
|
168,239 | $4,051,195 | |
| 6 | NVS |
Novartis AG
|
21,447 | $3,361,173 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
56,454 | $3,252,879 | |
| 8 | GSK |
GSK plc
This page
|
42,484 | $2,227,011 |
All Filings in GSK
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,227,011 | 42,484 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $2,379,185 | 43,109 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $1,757,446 | 35,837 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $1,320,091 | 30,586 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $1,049,472 | 27,330 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $837,946 | 21,630 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $772,381 | 22,838 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $831,090 | 20,330 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $524,447 | 13,622 | Shares | Sole | 2024-08-02 | |
| No filing history on record for this holder in this stock. | ||||||